ArticleFrontiers in immunology2022

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.

Catherine E Raptis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.